Phase I Milestone definition

Phase I Milestone. 5.5.1 “Pre-existing [...***...] Nanobodies” 2.7.1 “Program-Specific Patent Rights” 7.2.4 “Project Liaison” 2.6.4 [...***...] 8.7.4 “Research Materials” 2.10 “Research Program Year 1” 1.91 “Research Program Year 2” 1.91 “Research Program Year 3” 1.91 “Reserved [...***...] Target Combination” 2.12.4 “Royalty Period” 5.6.5 “Safety Termination” 8.3 “Second Product” 5.5.1 “Sensitive Information” 10.2 “Substitute Target” 2.5.1 “Target Addition” 2.5.4
Sample 1Sample 2Sample 3
Phase I Milestone. 5.5.1 “Pre-existing […***…] Nanobodies” 2.7.1 ‘Program Nanobody Controls” 5.5.1
Sample 1Sample 2

Examples of Phase I Milestone in a sentence

  • All financial statements of Guarantor heretofore delivered to Mezzanine Lender fairly present the financial condition of Guarantor as of the respective dates thereof, and no materially adverse change has occurred in the financial conditions reflected therein since the respective dates thereof.

  • The B Warrants will be exercisable for a period equal to the lesser of five years and 30 days after the first press release announcing satisfaction of the Phase I Milestone, but in no circumstances will the B Warrants expire in less than five years if the Phase 1 Milestone is not achieved and reported to the public by March 31, 2012.

  • The Company will, at its expense, file the appropriate Registration Statement for the resale of the common stock within 90 days of the date of the first press release announcing satisfaction of the Phase I Milestone.

  • Technical Area TwoTechnical Area Two proposers should develop a Phase I Milestone schedule and deliverables with a Period of Performance no longer than 14 months.

  • During the Phase I Milestone Schedule, Covad may also deploy or build out XGDSL Service equipment in any CO not included in the Phase I Areas unless such deployment or build out would materially interfere with, slow, or impair Covad’s ability to meet the Phase I Milestone Schedule.

  • If you’re submitting a request through the SSA system and you get the message “earnings already proven” and it's for Phase I Milestone 1-3, you need to make sure you submit proof of relationship items.

  • The following guidelines for acceptable dress should be followed: All shirts must have sleeves and cover the shoulders.

  • Form covering the post-Asset Sale period.3 In addition to the foregoing, before any compensation post-Petition Date compensation4 is approved for Scirocco, he should be required to explain why, as set forth in the SOFA, he5 received $87,927.20 of compensation during the 30-day period of September 15, 2016 through6 October 14, 2016, which exceeds by $32,377.20 the $55,550 amount he should have received7 over that period per the Comp.

  • While the Phase I Milestone Completion Date is targeted by UTGR to occur at the expiration of six (6) months following the Effective Date, such Phase I Milestone Completion Date shall in any event occur by the first anniversary of the Effective Date, subject, however, to extension as set forth in Section 4.2 or in this Section 4.3 above or in Section 4.3D below.

  • Year ended 30 JuneEPSCentsSTI$Share price at 30 June$2009(2.6)-6.002010(12.3)85,0004.602011(19.6)13,7612.922012(21.6)304,0003.202013(0.1)140,0002.20 The decrease in the negative earnings per share in the current year was mainly due to the US$15.0m (AU$15.4m) revenue from GE- Hitachi Global Laser Enrichment (‘GLE’) for the successful completion of the Test Loop Program Phase I Milestone.

Related to Phase I Milestone

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestone means an event or task described in the Implementation Plan which, if applicable, must be completed by the relevant Milestone Date;

  • Milestone Event has the meaning set forth in Section 8.4.

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Sales Milestone Payment is defined in Section 5.3.

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase II Study means a study in humans of the safety, dose ranging or efficacy of a product, as further defined in 21 C.F.R. § 312.21(b) (or the equivalent thereof outside the United States).

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.